Speakers - Advanced Therapies Week

Alex Bloom

Senior Vice President, Technical Operations • AviadoBio

Alex Dahmani

Director of Business Development • Adaptive Biotechnologies

Allen Feng

Co-Founder and Chief Scientific Officer • HebeCell Corp

Allyson Berent

Chief Science Officer • Foundation for Angelman Syndrome Therapeutics

Amit Agarwal

Managing Director • Deloitte

Amritha Jaishankar

Executive Director, Cell and Gene Therapy Center • IQVIA

Amy DuRoss

President, Cell and Gene Therapy • CSafe Global

Amy House

Integration & Transition Lead, Former: Senior Director, Chief of Staff to Chief Medical Officer • Gyroscope

Ana Rosa Sáez Ibáñez

Research Analyst, Clinical Accelerator and Venture Fund • Cancer Research Institute

Andreas Kouri

Senior Vice President, Supply Chain Logistics • ElevateBio

Andrew Olaye

Executive Director, Market Access & Partnerships EMEA • Orchard Therapeutics

Andy Holt

Chief Commercial Officer • Cellistic

Angela Justice

Chief People Officer • TCR2 Therapeutics

Anne Rowzee

Associate Director for Policy, Office of Tissues and Advanced Therapies • FDA

Anthony Davies

Founder & Chief Executive Officer • Dark Horse Consulting

Arnaud Deladeriere

Director of Process Development • Triumvira Immunologics

Arthur Stril

Chief Business Officer • Cellectis

Arun Das

Chief Business Officer • Cabaletta Bio

Åsa Hagner Mcwhirter

Principal Scientist • Cytiva

Azadeh Golipour

Chief Technical Officer • AVROBIO

Becky Johnson-Kent

Vice President, Europe & Women in Advanced Therapies (WiAT) Programme Lead • Phacilitate

Benoit Bossuge

Head of Strategic Sourcing • CRISPR Therapeutics

Beth Gardner

Senior Director, Patient Supply • Beam Therapeutics

Boro Dropulic

Executive Director • Caring Cross

Brad Carlin

Senior Advisor, Statistics and Data Science • PharmaLex GmbH (Biopharma excellence)

Brahm Goldstein

Vice President, Research and Development, Hematology • CSL Behring

Bruce Levine

Barbara and Edward Netter Professor in Cancer Gene Therapy; President, International Society for Cell & Gene Therapy • University of Pennsylvania

Bryan Poltilove

Operational Partner • Broadoak Capital Partners

Cameron Gardner

Director of Research • JURA Bio

Carl H. June

Director of the Center for Cellular Immunotherapies at the Perelman School of Medicine • University of Pennsylvania

Chris Brown

Director of Discovery • Metagenomi

Chris McClain

Senior Vice President of Sales and Business Development • Be The Match BioTherapies

Chris Min

Chief Executive Officer & Chief Medical Officer • Longeveron

Cintia Piccina

• AdaptImmune

Courtney Horvarth

Global Head of Strategy, Planning & Operations, Translational Medicine & Childhood Cancer Advocate • Novartis

Courtney Wells

Senior Vice President, Development Operations • Talaris Therapeutics

Craig Hasilo

Cynthia Pussinen

Chief Technical Officer • Spark Therapeutics

Dan Kemp

President and Chief Executive Officer • Wugen

Dan Strange

Chief Technology Officer • Cellular Origins, A TTP Company

Dave Lennon

Chief Executive Officer • Satellite Bio

David Barrett

Chief Executive Officer • Mayo Clinic

David Chang

Chief Executive Officer • WuXi Advanced Therapies

David Hermanson

Senior Manager, CGT Applications • Bio-Techne

David Hodl

Head of Business Development • Invetech

David Sheehan

President & Chief Executive Officer • Nucleus Biologics

David Sourdive

Co-Founder and EVP CMC & Manufacturing • Cellectis

David Yoder

Senior Manager of Product Strategy • Aldevron

Dominic Clarke

Chief Technical Officer, Cell and Gene Therapy • Discovery Life Sciences

Don Healey

Chief Technology Officer • Adicet Bio

Emily Chee

General Manager, Americas • Novartis Global Biotech Cooperations

Emily McGinnis

Chief Patient Officer • Taysha Gene Therapies

Emma Bjorgum

Vice President, Client Services, DNA • Aldevron

Eric Hacherl

Vice President, Head of Manufacturing • Spark Therapeutics

Erin Leckrone

Senior Director Clinical Trials • Be The Match BioTherapies

Essra Ridha

Chief Medical Officer • AVROBIO

Eytan Abraham

Vice President & Business Head, Cell Therapy, Gene Therapy • Nucleic Acids

Fabio Fachin

Head of Cell Therapy Process Development, Automation and Digital Technologies • Takeda

Farah Speer

Senior Vice President, Corporate Communications and External Relations • AviadoBio

Faraz Ali

Chief Executive Officer • Tenaya Therapeutics

Fran Gullo

Scientific Director, Gift of Life Center for Cell and Gene Therapy • Gift of Life Biologics

Frank Borriello

Chief Executive Officer • Alloplex Bio

Frank Thielmann

Head Lean, Global Operational Excellence • Takeda

Fred Chereau

Founder and Chief Executive Officer • LogicBio Therapeutics

Friedrich Graf Finckenstein

Chief Medical Officer • Iovance Biotherapeutics Inc

George Buchman

Vice President, Pre-Clinical and Process Development • Catalent Cell and Gene Therapy

Glenn Lumpkin

Director of Technical Services • CAI

Gregg Nyberg

Chief Technology Officer • Landmark Bio

Gregory Fiore

Founder and Chief Executive Officer • Exacis Biotherapeutics

Gwen Binder

President, Science & Techology • Cabaletta Bio

Gwen Nichols

Chief Medical Officer • The Leukemia & Lymphoma Society

Hanna Lesch

Chief Technology Officer • Exothera

Heather Stefanski

Vice President Medical Services • Be The Match BioTherapies

Irina Kadiyala

Senior Director & Head, Heme Process Development • Vertex Cell and Gene Therapies

J Kelly Ganjei

President and Chief Executive Officer • AmplifyBio

Jaeseung Lim

Chief Executive Officer & Chief Scientific Officer • Cellatz Therapeutics

James Kusena

Vice President, Bioprocessing & Applications • MicrofluidX

James Miskin

Chief Technical Officer • Oxford BioMedica (UK) Ltd

Jason B. Litten

Chief Medical Officer • Chimeric Therapeutics

Jean Stanton

Director, Global Cell Collection • Janssen

Jeff Liter

President and Chief Executive Officer • Luminary Therapeutics

Jeff Masten

Chief Operating Officer • Theragent

Jeffrey Boyd

Partner, Global Healthcare & Life Sciences Practice • Heidrick & Struggles

Jennifer Chow

Chief Executive Officer & Managing Director • Chimeric Therapeutics

Jennifer Fenwick

Senior Manager, Personalized Supply Chain • World Courier

Jenny Holt

Senior Vice President, Programme and Portfolio Management • Ray Therapeutics

Jenny Ligon

Associate Director, Workforce Development • National Center for Therapeutics Manufacturing (NCTM)

Jian Irish

President and Chief Operating Officer • Metagenomi

Joanne Brewer

Chief Scientific Officer • AdaptImmune

John Balchunas

Workforce Director • The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL)

John Campbell

Director, Tissues, Cells & Advanced Therapeutics • Scottish National Blood & Transplant Service

John Lee

Senior Vice President of Cell Therapy • Center for Breakthrough Medicines

John Maslowski

Chief Commercial Officer • Forge Biologics

John Rasko

Professor • University of Sydney

Jörg Schneider

Director, Principal Consultant • BioPharma Excellence

Joy Aho

Director of Product Management • Be The Match BioTherapies

Judith Koliwer

PhD Principal Consultant, Cell & Gene Therapy • Körber Pharma Software

Julie G. Allickson

Director, Mayo Clinic Center for Regenerative Medicine & Associate Professor of Regenerative Medicine • Mayo Clinic

Julie Lenzer

Chief Innovation Officer • ARMI | BioFabUSA

Justin McCue

Chief Technical Officer • Avectas

Karen Walker

Chief Technical Officer • Kyverna Therapeutics

Kent Thorup

Regional Vice President • QuickSTAT Global Life Science Logistics

Kevin Ramdas

Director, Clinical Operations • Longeveron

Kim Raineri

Chief Technology Officer • Aspen Neuroscience

Kimberly Goodspeed

Assistant Professor • University of Texas Southwestern Medical Center

Kimberly Negrin

Business Unit Leader • Stoic Bio

Kristin Viswanathan Wolff

Vice President, Market Access • bluebird bio

Kristy Shipulski

Vice President, Supply Chain Management • Vertex Cell and Gene Therapies

Lara Silverman

Founder • LIS BioConsulting

Lee Buckler

Leela Paris

Vice President, Process Engineering and Manufacturing, VCGT CMC Cell Manufacturing, • Vertex Cell and Gene Therapies

Lesley Chan

Director of Process Innovation • bluebird bio

Li Ou

Vice President • Genemagic Bio

Lili Belcastro

Senior Principal Scientist, Cell and Gene Therapy Raw Materials • Bristol Myers Squibb

Lior Raviv

Chief Technical Officer • Pluri

Lisa Deschamps

Chief Executive Officer • AviadoBio

Lisa McClain-Moss

Vice President, Manufacturing • Longeveron

Lisa Ward

Co-Founder • Tough2gether Against DIPG/DMG

Lung-I Cheng

Vice President, Cell and Gene Therapy • AmerisourceBergen

Lydia Jordan

Principal Investigator, CGT Clinical Supply Chain Lead • GlaxoSmithKline

Maia Hansen

Chief Operating Officer • Athersys

Marc Wolfgang

Vice President of Technical Development • BioNTech

Mark Sawicki

President & Chief Executive Officer • Cryoport Systems

Mark Truscheim

Strategic Director, NEWDIGS Initiative Institute for Clinical Research and Health Policy Studies • Tufts Medical Center

Marlin Frechette

Chief Quality & Compliance Officer • Fujifilm Irvine Scientific

Matthew Hewitt

Executive Director, Scientific Services, Cell and Gene Therapy • Charles River

Matthew Hewitt

Executive Director, Scientific Services, Cell & Gene Therapy (CGT) • Charles River

Matthew Lakelin

Co-Founder, Vice President of Scientific Affairs & Product Development • TrakCel

Matthew Li

Director, Cell Therapy CMC • Tome Biosciences

Matthew Toomey

Business Development Director • Merit

Matthew Weaver

Senior Director, Process Development • Spirovant

Mayasari Lim

Associate Director, Custom Business • Fujifilm Irvine Scientific

Meghan Verschoor

Associate Director, Data Sciences • Turnstone Bio

Michael E. Meyers

Managing Director, Head of Investment Banking; Interim Chief Executive Officer, Cell BT • H.C.WainWright&Co

Michael Lawlor

Professor • Medical College of Wisconsin

Michael Von Forstner

Global Head of Clinical Safety and Pharmacovigilance • Biogen

Michalle Adkins

Director, Life Sciences Strategy • Emerson

Miguel Forte

President Elect • International Society for Cell & Gene Therapy

Mona Jhaveri

Senior Vice President, Technical Operations • Music Beats Cancer

Neal Flomenberg

Chief Scientific Officer • Tevogen

Nicole Paulk

Professor • University of California San Francisco

Nisha Durand

Principal Research Technologist • Mayo Clinic

Ohad Karneili

Chief Executive Officer • Adva Biotechnology

Olivier Negre

Chief Scientific Officer • Smart-Immune

Øystein Åmellem

Director, Cell Biology • Thermo Fisher Scientific Inc

Pascal Touchon

President and Chief Executive Officer • Atara Biotherapeutics

Pete Robinson

Vice President, Medical and Scientific Management, Head, Cell and Gene Therapy Consortium • Syneos Health

Peter Olagunju

Chief Technology Officer • TCR2 Therapeutics

Peter Peumans

Peter Walters

Fellow, Advanced Therapies • CRB

Peter Zandstra

Professor • University of British Columbia

Phyllis I. Warkentin

Chief Medical Officer • Foundation for Accreditation Cellular Therapy (FACT)

Pierre Boulas

Head of Medical Devices and Packaging Development • Biogen

Raisa Lowe

Vice President, Head of CMC and Quality • Arbor Biotechnologies

Ramin Baghirzade

Senior Director, Gene Therapy • Charles River

Ramona Repaczki-Jones

Senior Director, Commercial Treatment Center Operations, Cell Therapy • Iovance Biotherapeutics Inc

Rebecca Lim

Senior Vice President – Scientific Affairs • Prescient Therapeutics

Ricardo Baptista

Chief Technology Officer • Alder Therapeutics

Rob Tressler

Chief Scientific Officer • Excellos

Robert Hughes

Vice President & General Manager • Miltenyi Biotec

Robert Newman

Chief Scientific Officer • Fujifilm Irvine Scientific

Roel Gordijn

Chief Commercial Officer • Polyplus

Ronit Slotky

Director, Cell Therapy Manufacturing Facility • Hackensack University Medical Center

Ryan Crisman

Chief Technical Officer • Umoja Biopharma

Ryan Leahy

Vice President of Research • Phacilitate

Ryan Saadi

Founder, Chair and Chief Executive Officer • Tevogen

Samik Basu

Chief Scientific Officer • Cabaletta Bio

Samik Upadhaya

Assistant Director of Scientific Affairs • Cancer Research Institute

Sarah Busch

Vice President of Regenerative Medicine, Head of Nonclinical Development • Athersys

Scott Bertch

Executive Director, Clinical Site Head • Tenaya Therapeutics

Scott Gottesman

Vice President, Human Resources • AVROBIO

Scott Jones

Senior Vice President & Chief Scientific Officer • BioBridge Global

Sean McAuliffe

Chief Commercial Officer • Taysha Gene Therapies

Serene Forte

Senior Vice President and Head of Genetic Medicine • RELIEF Therapeutics

Sharon Hesterlee

Executive Vice President, Chief Research Officer • Muscular Dystrophy Association USA

Shreenal Patel

Executive Vice President, Patient Supply • Achilles Therapeutics

Stephen Sullivan

Founder • Lindville Bio

Steve Doares

Senior Vice President US Manufacturing and Head of Raleigh Allogeneic CAR-T Facility • Cellectis

Steve Kanner

Chief Scientific Officer • Caribou Biosciences

Stuart Gibb

Scientific Strategy Lead • Terumo Blood and Cell Technologies

Sujay Kango

Chief Executive Officer • Tmunity

Sumit Verma

Senior Vice President, Commercial Manufacturing • Iovance Biotherapeutics Inc

Susan B. Nichols

Chief Business Officer • ViroCell Biologics

Suyash Prasad

Chief Medical Officer and Head of Research & Development • AviadoBio

Sven Kili

Chief Executive Officer • Antion Biosciences

Tay Salimullah

Vice President, Head of Global Value & Access, Novartis Gene Therapies • Novartis

Teonna Woolford

Chief Executive Officer • Sickle Cell Reproductive Health Education Directive

Thomas Bollenbach

Chief Technology Officer • ARMI

Tiffany M. Clement

Cell Therapies Core Inventory Management & Support Services Manager • Moffitt Cancer Center

Timothy D. Hunt

Chief Executive Officer • Alliance for Regenerative Medicine

Tom Whitehead

Founder • Emily Whitehead Foundation

Tony Ward

Chief Technology Officer • Curate Biosciences

Tony Wells

CEO • Merit

Troels Jordansen

Chief Executive Officer • GlycoStem

Vincent Ling

Senior Director • Takeda

Vishal Agrawal

Vice President, CMC and Process Development • Eikonoklastes Therapeutics

Will Junker

Head of Vector Manufacturing Quality • Kite Pharma

Wilson Bryan

Director, Office of Tissues and Advanced Therapies • FDA

Wolfgang Künnecke

Vice President of Bioanalytics • 908 Devices

Xavier De Mollerat Du Jeu

Senior Director of Research and Development • Thermo Fisher Scientific Inc

Yossi Schwartz

Professor, Pathology, Molecular and Cell Based Medicine at the Icahn School of Medicine • Mount Sinai Health System

Zankar Desai

Assistant Technical Director, Cell Therapy Testing Lab • Dana-Farber Cancer Institute

Zhimei Du

Vice President, Translational Research and Early Development • Landmark Bio

2023 Speakers